Goods & Services

Pharmaceutical and veterinary preparations; Sanitary preparations for medical use; Dietetic substances adapted for medical use; Disinfectants. Wholesaling and retailing of all kinds of pharmaceutical and veterinary preparations, preparations for medical purposes, Dietetic substances, Disinfectants; Advertising; Business management; Business administration; Office functions; Organisation of trade fairs and exhibitions for commercial or advertising purposes. Transport; Delivery; Distribution.

Abstract

The present invention claims the use of olive (Olea europaea L.) and pomegranate (Punica granatum) plant extracts and of various combinations of said extracts, some additionally including a probiotic, which allow a synergistic effect between the bioactive components thereof, for the purpose of preparing dietary supplements, functional foods/beverages, food additives and drugs for use in caring for human health.

IPC Classes  ?

• A23L 1/30 - containing additives (A23L 1/308 takes precedence);;
• A23L 2/02 - Non-alcoholic beveragesDry compositions or concentrates thereforPreparation or treatment thereof containing fruit or vegetable juices
• A23L 2/52 - Adding ingredients
• A23L 2/84 - Clarifying or fining of non-alcoholic beveragesRemoving unwanted matter using microorganisms or biological material, e.g. enzymes
• A61K 36/185 - Magnoliopsida (dicotyledons)
• A61K 36/63 - Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
• A61K 36/31 - Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
• A61P 9/12 - Antihypertensives
• A61P 3/06 - Antihyperlipidemics

Abstract

An orally administrable immunostimulant product comprises a microencapsulated cytokine and an enteric protection polymer to protect the cytokine, the cytokine is a fish, mollusc or crustacean cytokine, preferably a recombinant cytokine such as tumor necrosis factor α (TNFα) over-expressed in a host microorganism.

IPC Classes  ?

• A61K 9/50 - Microcapsules
• A61K 39/39 - Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
• A61K 38/19 - CytokinesLymphokinesInterferons

Abstract

The present invention relates to new pomegranate extracts, combined or not with soluble fiber, compositions free of any kind of organic solvent, soluble in cold water in high concentration, with very low sugar content and specially standardized to punicalagins, and its addition to foods to provide nutritional products and beverages with increased antioxidant capacity to be used as a source of punicalagins for preventing or treating cardiovascular diseases, plaque build-up in the arteries, arterial hypertension, and metabolic syndrome.

IPC Classes  ?

• A23C 9/152 - Milk preparationsMilk powder or milk powder preparations containing additives
• A23K 1/18 - specially adapted for particular animals
• A23L 1/30 - containing additives (A23L 1/308 takes precedence);;
• A23L 1/318 - Tenderised or flavoured meat pieces, e.g. obtained by injecting solutions; Macerating solutions
• A23L 1/325 - Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes
• A23L 2/52 - Adding ingredients
• A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
• A61P 9/12 - Antihypertensives
• A61P 3/06 - Antihyperlipidemics
• A23L 3/3472 - Compounds of undetermined constitution obtained from animals or plants
• A23B 4/18 - Preserving with chemicals not covered by groups or in the form of liquids or solids

Abstract

The present invention relates to nutritional products containing hydroxytyrosol, particularly food products (i.e: fortified edible oils and fortified edible oil-containing products) and dietary supplements (i.e.: soft gel capsules containing fortified edible oils) with increased antioxidant capacity to be used as a source of hydroxytyrosol for preventing or treating cardiovascular diseases, plaque build-up in the arteries, arterial hypertension, and metabolic syndrome, thanks to the nutritional supply of an hydroxytyrosol rich composition.

IPC Classes  ?

• A23D 7/05 - Working-up characterised by essential cooling
• A23D 9/007 - Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
• A23L 1/30 - containing additives (A23L 1/308 takes precedence);;
• A61K 31/05 - Phenols
• A61K 36/63 - Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
• A61P 9/10 - Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
• A61P 9/12 - Antihypertensives
• A61P 39/06 - Free radical scavengers or antioxidants

Abstract

Hydroxytyrosol is extracted from olives and/or from the solid residues of olives after the extraction of olive oil, by carrying out acid hydrolysis at a temperature within the range of 110°C to 140°C and at a pH within the range of 1.0 to 6.0, and by purifying the obtained solution on a column containing acid activated anion exchange resins, and a column containing an adsorbent non-ionic resin; both columns being eluted with water to recover the hydroxytyrosol.

IPC Classes  ?

• C07C 37/01 - Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis
• C07C 39/11 - Alkylated hydroxy benzenes containing also acyclically bound hydroxy groups, e.g. saligenol
• B01J 3/04 - Pressure vessels, e.g. autoclaves